| Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer |
2022 |
Gatius, S.; Jove, M.; Megino Luque, C.; Albertí Valls, M.; Yeramian, A.; Bonifaci, N.; Piñol, M.; Santacana, M.; Pradas, I.; Llobet Navas, D.; Pamplona, R.; Matías Guiu, X.; Eritja, N. |
Article d'investigació |
| Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition |
2022 |
Ruiz Mitjana, A.; Navaridas, R.; Vidal Sabanés, M.; Perramon Güell, A.; Yeramian, A.; Felip, I.; Eritja, N.; Egea, J.; Encinas, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. |
2022 |
Megino Luque, C.; Sisó, P.; Mota Martorell, N.; Navaridas, R.; de la Rosa, I.; Urdanibia, I.; Albertí Valls, M.; Santacana, M.; Pinyol, M.; Bonifaci, N.; Macià, A.; Llobet Navas, D.; Gatius, S.; Matia |
Article d'investigació |
| M-CSF as a therapeutic target in BRAF V600E melanoma resistant to BRAF inhibitors |
2022 |
Barceló, C.; Sisó, P.; de la Rosa, I.; Megino Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet Llopart, N.; Puig, S.; Matías Guiu, X.; Martí, R.M.; Maci |
Article d'investigació |
| Endometrial PTEN Deficiency Leads to SMAD2/3 Nuclear Translocation. |
2021 |
Eritja, N.; Navaridas, R.; Ruiz Mitjana, A.; Vidal Sabanés, M.; Egea, J.; Encinas, M, Matias Guiu, X.; Dolcet, X. |
Article en revista divulgativa |
| Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma. |
2021 |
Sanegre, S.; Eritja, N.; de Andrea, C.; Diaz Martin, J.; Diaz Lagares, Á.; Jácome, M.A.; Salguero Aranda, C.; García Ros, D.; Davidson, B.; Lopez, R.; Melero, I.; Navarro, S.; Ramon Y Cajal, S.; de Al |
Article d'investigació |
| T-Type calcium channels as potential therapeutic targets in vemurafenib-resistant BRAF(V600E) melanoma |
2020 |
Barceló, C.; Sisó, P.; Maiques, O.; García-Mulero, S.; Sanz-Pamplona, R.; Navaridas, R.; Megino, C.; Felip, I.; Urdanibia, I.; Eritja, N.; Soria, X.; Piulats, J.M.; Penin, R.M.; Dolcet, X.; Matías-Gui |
Article d'investigació |
| Small-Molecule Inhibitors (SMIs) as an Effective Therapeutic Strategy for Endometrial Cancer |
2020 |
Megino-Luque, C.; Moiola, C.P.; Molins-Escuder, C.; López-Gil, C.; Gil-Moreno, A.; Matias-Guiu, X.; Colas, E.; Eritja N. |
Article d'investigació |
| Autophagy in the physiological endometrium and cancer |
2020 |
Devis-Jauregui, L.; Eritja, N.; Davis, M.L.; Matias-Guiu, X.; Llobet-Navàs, D. |
Article d'investigació |
| Intratumor heterogeneity in endometrial serous carcinoma assessed by targeted sequencing and multiplex ligation-dependent probe amplification (MLPA). A DESCRIPTIVE STUDY. |
2020 |
Cuevas D; Velasco A; Vaquero M; Santacana M; Gatius S; Eritja N; Estaran E; Matias-Guiu X. |
Article d'investigació |
| Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis. |
2019 |
Dosil, M.A.; Navaridas, R.; Mirantes, C.; Tarragona, J.; Eritja, N.; Felip, I.; Urdanibia, I.; Megino, C.; Domingo, M.; Santacana, M.; Gatius, S; Piñol, C.; Barceló, C.; Maiques, O.; Macià, A.; Velasc |
Article d'investigació |
| Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer. |
2019 |
Felip I; Moiola CP; Megino-Luque C; Lopez-Gil C; Cabrera S; Solé-Sánchez S; Muñoz-Guardiola P; Megias-Roda E;Pérez-Montoyo H;Alfon J;Yeste-Velasco M; Santacana M; Dolcet X; Reques A; Oaknin A; Rodrígu |
Article d'investigació |
| Targeted sequencing with a customized panel to assess histological typing in endometrial carcinoma. |
2019 |
Cuevas D; Valls J; Gatius S: Roman-Canal B; Estaran E; Dorca E; Santacana M; Vaquero M; Eritja N; Velasco A; Matias-Guiu X. |
Article d'investigació |
| High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition |
2018 |
Zhu C; Farre G; Zanga D; Lloveras J; Michelena A; Ferrio JP; Voltas J; Slafer GA; Savin R; Albajes R; Eizaguirre M; Lopez C; Cantero-Martínez C; Díaz-Gómez J; Nogareda C; Moreno JA; Angulo E; Estany J |
Review |
| A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. |
2017 |
Eritja, N.; Felip, I.; Dosil, M.A.; Vigezzi, L.; Mirantes, C.; Yeramian, A.; Navaridas, R.; Santacana, M.; Llobet Navas, D.; Yoshimura, A.; Nomura, M.; Encinas, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias. |
2017 |
Dosil, MA; Mirantes, C; Eritja, N; Felip, I; Navaridas, R; Gatius, S; Santacana, M; Colàs, E; Moiola, C; Schoenenberger, JA; Encinas, M; Garí, E; Matias-Guiu, X; Dolcet, X. |
Article d'investigació |
| Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer |
2017 |
Eritja N; Chen BJ; Rodríguez-Barrueco R; Santacana M; Gatius S; Vidal A; Martí MD; Ponce J; Bergadà L; Yeramian A; Encinas M; Ribera J; Reventós J; Boyd J; Villanueva A; Matias-Guiu X; Dolcet X; Llobe |
Article d'investigació |
| Endometrial Carcinoma: Specific Targeted Pathways. |
2017 |
Eritja N; Yeramian A; Chen BJ; Llobet-Navas D; Ortega E; Colas E; Abal M; Dolcet X; Reventos J; Matias-Guiu X. |
Review |
| Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients. |
2017 |
Eritja N; Jove M; Eldevik Fasmer K; Gatius S; Portero-Otin M; Trovik J; Krakstad C; Sol J; Pamplona R; Haldorsen IS; Matias-Guiu X. |
Article d'investigació |
| Oral intake of genetically engineered high-carotenoid corn ameliorates hepatomegaly and hepatic steatosis in PTEN haploinsufficient mice. |
2016 |
Eritja N; Arjo G; Santacana M; Gatius S; Arcal L; Serrano JC; Pamplona R; Dolcet X; Piñol C; Christou P; Matias-Guiu X; Portero-Otin M. |
Article d'investigació |
| Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma, but not myeloid malignancies. |
2016 |
Mirantes C, Dosil MA, Hills D, Yang J, Eritja N, Santacana M, Gatius S, Vilardell F, Medvinsky A, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Effects of the multikinase inhibitors Sorafenib and Regorafenib in PTEN deficient neoplasias |
2016 |
Mirantes C, Dosil MA, Eritja N, Felip I, Gatius S, Santacana M, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism |
2016 |
Jove M; Gatius S; Yeramian A; Portero-Otin M; Eritja N; Santacana M; Ruiz M; Pamplona R; Matias-Guiu X. |
Article d'investigació |
| Modeling glands with PTEN deficient cells and microscopic methods for assessing PTEN loss: endometrial cancer as a model. |
2015 |
Eritja N, Santacana M, Maiques O, Gonzalez-Tallada X, Dolcet X, Matias-Guiu X: |
Article d'investigació |
| ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas |
2014 |
Alonso-Alconada L, Eritja N, Muinelo-Romay L, Barbazan J, Lopez-Lopez R, Matias-Guiu X, Gil-Moreno A, Dolcet X, Abal M |
Article d'investigació |
| Combinatorial Therapy Using Dovitinib and ICI182.780 (Fulvestrant) Blocks Tumoral Activity of Endometrial Cancer Cells |
2014 |
Eritja N, Domingo M, Dosil MA, Mirantes C, Santacana M, Valls J, Llombart-Cussac A, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| An inducible knock-out mouse to model cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias |
2013 |
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X |
Article d'investigació |
| Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells |
2013 |
Bergadà, L.; Sorolla, A.; Yeramian, A.; Eritja, N.; Mirantes, C.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture |
2013 |
Chen N, Eritja N, Lock R, Debnath J. |
Article d'investigació |
| Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometriaT cells and drives PTEN loss-induced hyperplasic growth |
2013 |
Eritja, N.; Mirantes, C.; Llobet, D.; Yeramian, A.; Bergadà, L.; Dosil, M.A.; Domingo, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| Three-dimensional epithelial cultures: a tool to model cancer development and progression |
2013 |
Eritja N, Dolcet X, Matias-Guiu X. |
Review |
| ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance |
2012 |
Eritja N, Mirantes C, Llobet D, Masip G, Matias-Guiu X, Dolcet X. |
Article d'investigació |
| Nuclear factor-kappa B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1 alpha independent manner |
2011 |
Yeramian, A.; Santacana, M.; Sorolla, A.; Llobet, D.; Encinas, M.; Velasco, A.; Bahi, N.; Eritja, N.; Domingo, M.; Oliva, E.; Dolcet, X.; Matias Guiu, X. |
Article d'investigació |
| KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. |
2011 |
Llobet, D.; Eritja, N.; Domingo, M.; Bergada, L.; Mirantes, C.; Santacana, M.; Pallares, J.; Macià, A.; Yeramian, A.; Encinas, M.; Moreno Bueno, G.; Palacios, J.; Lewis, R.E.; Matias Guiu, X.; Dolcet, |
Article d'investigació |
| The multikinase inhibitor sorafenib induces apoptosis and sensitizes endometrial cancer cells to TRAIL by different mechanisms |
2010 |
Llobet, D.; Eritja, N.; Encinas, M.; Yeramian, A.; Pallares, J.; Sorolla, A.; Santacana, M.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
| A novel 3D culture system of polarized epithelial cells to study endometrial carcinogenesis |
2010 |
Eritja N; Llobet D; Domingo M; Yeramian A; Matias-Guiu X; Dolcet X. |
Article d'investigació |
| A review of the aplications of tissue microarray technology in understanding the molecular features of endometrial carcinoma |
2009 |
Pallarés J; Santacana M; Puente S; López S; Yeramian A; Eritja N; Sorolla A; Llobet D; Dolcet X; Matias-Guiu X |
Review |
| Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutical view points |
2009 |
Llobet D; Pallares J; Yeramian A; Santacana M; Eritja N; Velasco A; Dolcet X; Matias-Guiu X |
Review |
| CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation. |
2009 |
Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X. |
Article d'investigació |
| Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma. |
2008 |
Pallarés J, Velasco A, Eritja N, Santacana M, Dolcet X, Cuatracasas M, Palomar-Asenjo V, Catasús Ll, Prat J, Matias-Guiu X. |
Article d'investigació |
| Nuclear factor-kappa B activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma |
2008 |
Gallel P; Pallares J; Dolcet X; Llobet D; Eritja N; Santacana M; Yeramian A; Palomar-Asenjo V; Lagarda H; Mauricio D; Encinas M; Matias-Guiu X |
Article d'investigació |
| Loss of heterozygosity in endometrial carcinoma |
2008 |
Velasco A; Pallarés J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X |
Review |
| CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells |
2008 |
Llobet D; Eritja N; Encinas M; Llecha N; Yeramian A; Pallares J; Sorolla A; Gonzalez-Tallada FJ; Matias-Guiu X; Dolcet X |
Article d'investigació |
| Antioxidants block proteasome inhibitor function in endometrial carcinoma cells |
2008 |
Llobet D; Eritja N; Encinas M; Sorolla A; Yeramian A; Schoenenberger JA; Llombart-Cussac A; Martí RM; Matias-Guiu X; Dolcet X |
Article d'investigació |
